| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| GALECTIN THERAPEUTICS INC | Chief Medical Officer | Restricted Stock Unit | 100,000 | $69,600 | $1.16 | 16 Jan 2026 | Direct |
| GALECTIN THERAPEUTICS INC | Chief Medical Officer | Common Stock | 0 | $0 | $3.65 | 06 Jan 2026 | Direct |
| GALECTIN THERAPEUTICS INC | Chief Medical Officer | Stock option (right to buy) | 65,000 | 16 Jan 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| GALT | GALECTIN THERAPEUTICS INC | 16 Jan 2026 | 2 | $0 | 4 | Chief Medical Officer | 21 Jan 2026, 16:50 |
| GALT | GALECTIN THERAPEUTICS INC | 02 Jan 2026 | 5 | -$232,402 | 4 | Chief Medical Officer | 06 Jan 2026, 16:53 |
| GALT | GALECTIN THERAPEUTICS INC | 31 Dec 2025 | 3 | -$23,095 | 4 | Chief Medical Officer | 05 Jan 2026, 16:07 |
| GALT | GALECTIN THERAPEUTICS INC | 17 Dec 2025 | 7 | -$101,403 | 4 | Chief Medical Officer | 19 Dec 2025, 16:06 |
| GALT | GALECTIN THERAPEUTICS INC | 13 Nov 2025 | 10 | -$447,472 | 4 | Chief Medical Officer | 14 Nov 2025, 16:02 |
| GALT | GALECTIN THERAPEUTICS INC | 23 Jan 2025 | 2 | $0 | 4 | Chief Medical Officer | 27 Jan 2025, 16:05 |
| GALT | GALECTIN THERAPEUTICS INC | 23 Dec 2024 | 3 | -$12,044 | 4 | Chief Medical Officer | 26 Dec 2024, 08:20 |
| GALT | GALECTIN THERAPEUTICS INC | 02 Aug 2024 | 0 | $0 | 3 | Chief Medical Officer | 05 Aug 2024, 08:38 |
| GALT | GALECTIN THERAPEUTICS INC | 01 Aug 2024 | 2 | $0 | 4 | Chief Medical Officer | 05 Aug 2024, 08:41 |